Idrofos 150 Tablet

Idrofos 150 Tablet

Idrofos 150 Tablet contains Ibandronic Acid (150mg), a bisphosphonate that slows bone loss and increases bone density by inhibiting osteoclast-mediated bone resorption. It is prescribed for the treatment and prevention of postmenopausal osteoporosis to reduce the risk of fractures.

Key Features

• Contains Ibandronic Acid 150mg
• Inhibits bone resorption and increases bone density
• Once-monthly dosing regimen
• Reduces the risk of osteoporotic fractures
• Manufactured by Sun Pharmaceutical Industries Ltd

Key Ingredients

• Ibandronic Acid 150mg

Uses

Suitable for postmenopausal women at risk of or diagnosed with osteoporosis, requiring bisphosphonate therapy to reduce fracture risk, as prescribed by a doctor.

Directions for Use

Take one tablet once a month on the same date each month, on an empty stomach with a full glass of plain water, at least 60 minutes before the first food or drink of the day. Remain upright for at least 60 minutes after taking.

Precautions

• Take only as prescribed by a registered doctor
• Do not lie down for at least 60 minutes after taking
• Inform your doctor of any kidney problems or difficulty swallowing
• Report any jaw pain, unusual thigh pain, or chest pain to your doctor
• Keep away from children

Legal Disclaimer: The product is guaranteed to be 100% genuine. Product images are for illustrative purposes only.